We are continuing to see the window wide open for taking biopharma and biotech companies public. This panel will focus on analyzing best practices for companies preparing for an IPO, the effects COVID has had, and how this process will be changed forever. We’ll talk to the CFO of Zentalis Pharmaceuticals, the first IPO after the pandemic began.
During this panel, we'll dive into:
• When is the best time and what are the best ways to drive the process
• Establishing the right internal and external teams
• The importance of a crossover round for a successful IPO
• How does a SPAC process compares to a traditional IPO
• Tradeoffs of virtual IPO road shows
Moderator:
Sarah Ashfaq, Partner, Goodwin Law
Panelists:
Brian Coleman, Managing Director, Global Head of Capital Markets & Sales, Locust Walk
Melissa Epperly, CFO, Zentalis Pharmaceuticals
Chris Gartin, Managing Director, Healthcare Investment Banking, Citi
Anup Marda, CFO, Cabaletta Bio
